Metronomic chemotherapy offers hope for children with neuroblastoma

Despite advances in treatment, survival rates for high-risk and relapsed/refractory neuroblastoma remain dismal, and options like autologous stem cell transplantation and immunotherapy are frequently unavailable in low- and middle-income countries. Given these stark realities, there is a critical need for alternative, more accessible therapies like metronomic chemotherapy (MC) to improve survival prospects for these children.

Read more: https://www.news-medical.net/news/20250123/Metronomic-chemotherapy-offers-hope-for-children-with-neuroblastoma.aspx